These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 18571864)

  • 1. Corticosterone and related receptor expression are associated with increased beta-amyloid plaques in isolated Tg2576 mice.
    Dong H; Yuede CM; Yoo HS; Martin MV; Deal C; Mace AG; Csernansky JG
    Neuroscience; 2008 Jul; 155(1):154-63. PubMed ID: 18571864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of corticotrophin-releasing factor receptor 1 antagonists on amyloid-β and behavior in Tg2576 mice.
    Dong H; Wang S; Zeng Z; Li F; Montalvo-Ortiz J; Tucker C; Akhtar S; Shi J; Meltzer HY; Rice KC; Csernansky JG
    Psychopharmacology (Berl); 2014 Dec; 231(24):4711-22. PubMed ID: 24862368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotrophin releasing factor accelerates neuropathology and cognitive decline in a mouse model of Alzheimer's disease.
    Dong H; Murphy KM; Meng L; Montalvo-Ortiz J; Zeng Z; Kolber BJ; Zhang S; Muglia LJ; Csernansky JG
    J Alzheimers Dis; 2012; 28(3):579-92. PubMed ID: 22045495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease.
    Campbell SN; Zhang C; Roe AD; Lee N; Lao KU; Monte L; Donohue MC; Rissman RA
    J Alzheimers Dis; 2015; 45(4):1175-84. PubMed ID: 25697705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease.
    Wati H; Kawarabayashi T; Matsubara E; Kasai A; Hirasawa T; Kubota T; Harigaya Y; Shoji M; Maeda S
    Brain Pathol; 2009 Jan; 19(1):48-57. PubMed ID: 18429966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress.
    Dong H; Goico B; Martin M; Csernansky CA; Bertchume A; Csernansky JG
    Neuroscience; 2004; 127(3):601-9. PubMed ID: 15283960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
    Bi Oh S; Suh N; Kim I; Lee JY
    Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
    Kuznetsova E; Schliebs R
    Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease amyloid-β pathology in the lens of the eye.
    Moncaster JA; Moir RD; Burton MA; Chadwick O; Minaeva O; Alvarez VE; Ericsson M; Clark JI; McKee AC; Tanzi RE; Goldstein LE
    Exp Eye Res; 2022 Aug; 221():108974. PubMed ID: 35202705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42).
    Rockenstein E; Mallory M; Mante M; Sisk A; Masliaha E
    J Neurosci Res; 2001 Nov; 66(4):573-82. PubMed ID: 11746377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of donepezil on amyloid-beta and synapse density in the Tg2576 mouse model of Alzheimer's disease.
    Dong H; Yuede CM; Coughlan CA; Murphy KM; Csernansky JG
    Brain Res; 2009 Dec; 1303():169-78. PubMed ID: 19799879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
    Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
    J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.
    Mucke L; Masliah E; Yu GQ; Mallory M; Rockenstein EM; Tatsuno G; Hu K; Kholodenko D; Johnson-Wood K; McConlogue L
    J Neurosci; 2000 Jun; 20(11):4050-8. PubMed ID: 10818140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral treatment with enoxaparin exacerbates amyloid plaque pathology in Tg2576 mice.
    Cui H; King AE; Jacobson GA; Small DH
    J Neurosci Res; 2017 Apr; 95(4):992-999. PubMed ID: 27546887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of stress and stress hormones on amyloid-beta protein and plaque deposition.
    Dong H; Csernansky JG
    J Alzheimers Dis; 2009; 18(2):459-69. PubMed ID: 19584430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lovastatin enhances Abeta production and senile plaque deposition in female Tg2576 mice.
    Park IH; Hwang EM; Hong HS; Boo JH; Oh SS; Lee J; Jung MW; Bang OY; Kim SU; Mook-Jung I
    Neurobiol Aging; 2003 Sep; 24(5):637-43. PubMed ID: 12885571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer's disease.
    Dong H; Csernansky CA; Martin MV; Bertchume A; Vallera D; Csernansky JG
    Psychopharmacology (Berl); 2005 Aug; 181(1):145-52. PubMed ID: 15778881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging-related increase in oxidative stress correlates with developmental pattern of beta-secretase activity and beta-amyloid plaque formation in transgenic Tg2576 mice with Alzheimer-like pathology.
    Apelt J; Bigl M; Wunderlich P; Schliebs R
    Int J Dev Neurosci; 2004 Nov; 22(7):475-84. PubMed ID: 15465277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tg-SwDI transgenic mice exhibit novel alterations in AbetaPP processing, Abeta degradation, and resilient amyloid angiopathy.
    Van Vickle GD; Esh CL; Daugs ID; Kokjohn TA; Kalback WM; Patton RL; Luehrs DC; Walker DG; Lue LF; Beach TG; Davis J; Van Nostrand WE; Castaño EM; Roher AE
    Am J Pathol; 2008 Aug; 173(2):483-93. PubMed ID: 18599612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice.
    Meilandt WJ; Cisse M; Ho K; Wu T; Esposito LA; Scearce-Levie K; Cheng IH; Yu GQ; Mucke L
    J Neurosci; 2009 Feb; 29(7):1977-86. PubMed ID: 19228952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.